Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis
The New England Journal of Medicine
•
November 07, 2025
Fish oil reduces cardiovascular events in hemodialysis
Daily fish-oil capsules lowered serious cardiovascular events in adults receiving long-term hemodialysis. *Double-blind randomized placebo-controlled trial; Level 1b (OCEBM).
- Level of evidence
- Level 1b (OCEBM)
- DocG quality score
- 7.0 / 10
Read the full summary free
Patients, intervention, outcomes, results, and clinical applicability in about 300 words — plus new summaries in your inbox 3× per week.
Sign in with Google
